Immune Therapeutics, Inc. Announces Advisory Board Appointments

NEXT STORY
OPKO Health, Inc. Announces Proposed Offering of Common Stock
PREV STORY
Trillium Therapeutics Announces Corporate Restructuring and Provides CD47 Program Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016 Eurobio Scientific has successfully upgraded its quality management ...

author_avatar
NASDAQ Market News

Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial of Once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

author_avatar
NASDAQ Market News

Aduro Biotech Chief Scientific Officer to Highlight the Potential of STING Activation in Cancer Immunotherapy in a Major Symposium at the 2016 American Association for Cancer Research Annual Meeting

BERKELEY, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), today announced ...

author_avatar
NASDAQ Market News